Professor Sir John Tooke FRCP PMedSci

“Drawing on the capacities of two world-class universities and our wider partnerships, CASMI offers the opportunity to rise to the challenge of reshaping the innovation pipeline for the benefit of both patients and the economy.”

Professor Sir John Tooke FRCP FRCPI FRCGP (Hon) FAcadMed (Hon) FMedSci was until 2015 Vice Provost (Health) and Head of the Medical School at UCL and Academic Director of UCL’s Academic Health Science Centre, UCL Partners.  Sir John is immediate past President of the Academy of Medical Sciences and is currently Executive Chairman of Academic Health Solutions, a Company offering high-end advisory services to improve population health and wealth worldwide through harnessing academic expertise. He is a member of the Independent Review Board for Google DeepMind Health and is on the main Board of Bupa for whom he chairs the Medical Advisory Council.

His clinical and research interests focus on diabetes and its vascular complications and he is a recipient of the European Association of Diabetes Camillo Golgi Award.  He is former Chair of Diabetes UK Professional Section and former President of the European Society for Microcirculation.  The University of Exeter was awarded a Queen’s Anniversary Prize for his work on the pathogenesis of diabetic microangiopathy.  In addition to more fundamental work on the complications of diabetes his research has embraced screening and service delivery and organisational issues and the patient’s perspective.

In 2007, he led the Inquiry for the Secretary of State for Health into Postgraduate Medical Education and Training, culminating in the final report, Aspiring to Excellence.  In the same year, he led a high-level group for the CMO on Barriers to Clinical Effectiveness, the report of which led to the creation of CLAHRCs (Collaborations for Leadership in Applied Health Research and Care). Most recently, he chaired the Academy of Medical Sciences’ report into Enhancing the Use of Scientific Evidence to Judge the Potential Benefits and Harms of Medicines, published in 2017, and he currently chairs UCL’s IGNITE programme for senior medical innovators.